Search results
Results From The WOW.Com Content Network
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
A Pap test may be performed according to guidelines, and testing for Neisseria gonorrhea and Chlamydia trachomatis may be performed as indicated. [24] A bimanual examination during early pregnancy will reveal that the uterus is enlarged, softened and globular; the external os may be dilated, but the internal os is typically closed. [ 24 ]
The Pap test is still widely used as a means of early cancer detection and is estimated to have reduced fatalities caused by cancer of the reproductive systems in women by half. [10] By some accounts, the pap test is considered the most significant advance in the control of cancer in the 20th century.
Around a third of Roblox players on the Xbox One play Adopt Me!. [23] Due to the presence of microtransactions in the game and the target demographic being young children, there have been instances of children spending large amounts of money on Adopt Me! , including one particular incident where a child from Australia spent $8,000 AUD (US$6,348 ...
Papanicolaou stain (also Papanicolaou's stain and Pap stain) is a multichromatic (multicolored) cytological staining technique developed by George Papanicolaou in 1942. [ 1 ] [ 2 ] [ 3 ] The Papanicolaou stain is one of the most widely used stains in cytology , [ 1 ] where it is used to aid pathologists in making a diagnosis.
Pap stain. Gynaecologic cytology, also gynecologic cytology, is a field of pathology concerned with the investigation of disorders of the female genital tract. [1] The most common investigation in this field is the Pap test, which is used to screen for potentially precancerous lesions of the cervix.
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, [1] used for reporting Pap smear results. It was introduced in 1988 [2] and revised in 1991, [3] 2001, [1] [4] [5] and 2014. [6]
The Pap test can be used as a screening test, but produces a false negative in up to 50% of cases of cervical cancer. [56] [57] Other concerns is the cost of doing Pap tests, which make them unaffordable in many areas of the world. [58] Confirmation of the diagnosis of cervical cancer or precancer requires a biopsy of the cervix.